Showing results (1251-1260 of 1,689) with videos related to
Sort By:
Pageof 169
European Journal of Heart Failure|April 10, 2026
Kidney Failure Risk Equation and Risk of Kidney and Cardiovascular Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Insights from PARADIGM-HFIris E Beldhuis, Brian L Claggett, Brendon L Neuen, et al.European Journal of Heart Failure|May 14, 2024
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trialMuthiah Vaduganathan, Brian L Claggett, Carolyn S P Lam, et al.Journal of the American College of Cardiology|January 2, 2025
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 TrialsHenri Lu, Toru Kondo, Brian L Claggett, et al.Circulation. Heart Failure|October 22, 2021
Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection FractionMasatoshi Minamisawa, Brian Claggett, Kota Suzuki, et al.Circulation. Cardiovascular Imaging|June 11, 2019
Diagnostic Accuracy of Advanced Imaging in Cardiac SarcoidosisSanjay Divakaran, Garrick C Stewart, Neal K Lakdawala, et al.JAMA Cardiology|September 27, 2024
Estimated Long-Term Benefits of Finerenone in Heart Failure: A Prespecified Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialMuthiah Vaduganathan, Brian L Claggett, Akshay S Desai, et al.Journal of the American Heart Association|April 23, 2025
Comprehensive Analysis of the Effects of Sacubitril/Valsartan According to Sex Among Patients With Heart Failure and Reduced Ejection Fraction in PARADIGM-HFMisato Chimura, Jawad H Butt, Shingo Matsumoto, et al.European Journal of Heart Failure|December 19, 2019
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fractionKieran F Docherty, Li Shen, Davide Castagno, et al.Nature Medicine|October 6, 2025
Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fractionMuthiah Vaduganathan, Brian L Claggett, Safia Chatur, et al.European Journal of Heart Failure|November 20, 2024
Effects of sacubitril/valsartan according to background beta-blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HFSharmistha Datta Gupta, Jawad H Butt, Eoghan G M McMurray, et al.Pageof 169